|
Name |
2-Propenal, 3-(2-furanyl)-2-methyl-
|
Molecular Formula | C8H8O2 | |
IUPAC Name* |
(Z)-3-(furan-2-yl)-2-methylprop-2-enal
|
|
SMILES |
C/C(=C/C1=CC=CO1)/C=O
|
|
InChI |
InChI=1S/C8H8O2/c1-7(6-9)5-8-3-2-4-10-8/h2-6H,1H3/b7-5-
|
|
InChIKey |
ZNBXZUKDRRRQJK-ALCCZGGFSA-N
|
|
Synonyms |
2-methyl-3(2-furyl)acrolein; FEMA No. 2704; 2-PROPENAL, 3-(2-FURANYL)-2-METHYL-; cinnamon acrolein; 65U4YZ14MX; alpha -Methylfurylacrolein; SCHEMBL1532601; ZINC1850921; AKOS000268597; .ALPHA.-METHYL-2-FURANACROLEIN; 2-FURANACROLEIN, .ALPHA.-METHYL-; METHYL-3-(2-FURYL)ACROLEIN, 2-; 3-(2-FURYL)-2-METHYLPROP-2-ENAL; 2-METHYL-3(2-FURYL)ACROLEIN [FHFI]; 2-METHYL-3-(.ALPHA.-FURYL)PROPENAL-2; 3-(2-(FURANYL)-2-METHYL-2-PROPENAL; .ALPHA.-METHYL-.BETA.-(2-FURYL)ACROLEIN; Q27263911
|
|
CAS | 874-66-8 | |
PubChem CID | 6435828 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 136.15 | ALogp: | 1.6 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 30.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.462 |
Caco-2 Permeability: | -4.357 | MDCK Permeability: | 0.00002200 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.351 | Plasma Protein Binding (PPB): | 90.80% |
Volume Distribution (VD): | 2.002 | Fu: | 18.61% |
CYP1A2-inhibitor: | 0.958 | CYP1A2-substrate: | 0.315 |
CYP2C19-inhibitor: | 0.4 | CYP2C19-substrate: | 0.523 |
CYP2C9-inhibitor: | 0.04 | CYP2C9-substrate: | 0.051 |
CYP2D6-inhibitor: | 0.014 | CYP2D6-substrate: | 0.159 |
CYP3A4-inhibitor: | 0.014 | CYP3A4-substrate: | 0.241 |
Clearance (CL): | 9.323 | Half-life (T1/2): | 0.802 |
hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.46 |
Drug-inuced Liver Injury (DILI): | 0.072 | AMES Toxicity: | 0.166 |
Rat Oral Acute Toxicity: | 0.267 | Maximum Recommended Daily Dose: | 0.32 |
Skin Sensitization: | 0.306 | Carcinogencity: | 0.856 |
Eye Corrosion: | 0.975 | Eye Irritation: | 0.994 |
Respiratory Toxicity: | 0.926 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000190 | 0.548 | D01ZJK | 0.204 | ||||
ENC000480 | 0.429 | D03KOZ | 0.194 | ||||
ENC000162 | 0.351 | D0T3NY | 0.190 | ||||
ENC001133 | 0.325 | D0GY5Z | 0.189 | ||||
ENC001629 | 0.303 | D0U5QK | 0.184 | ||||
ENC000189 | 0.297 | D0E9CD | 0.184 | ||||
ENC000678 | 0.297 | D0PQ3G | 0.181 | ||||
ENC000546 | 0.286 | D06NVJ | 0.178 | ||||
ENC001736 | 0.283 | D0X9RY | 0.178 | ||||
ENC003478 | 0.269 | D07HBX | 0.170 |